galactosamine has been researched along with iloprost in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bienzle, U; Blitstein-Willinger, E; Grundmann, HJ; Hähnle, U; Hegenscheid, B; Sahlmüller, G | 1 |
| Tiegs, G; Wendel, A; Wolter, M | 1 |
2 other study(ies) available for galactosamine and iloprost
| Article | Year |
|---|---|
Inhibition of endotoxin-induced macrophage tumor necrosis factor expression by a prostacyclin analogue and its beneficial effect in experimental lipopolysaccharide intoxication.
Topics: Animals; Blotting, Northern; Cells, Cultured; Dose-Response Relationship, Drug; Galactosamine; Iloprost; Lipopolysaccharides; Macrophages; Male; Mice; Mice, Inbred C57BL; RNA, Messenger; Transcription, Genetic; Tumor Necrosis Factor-alpha | 1992 |
Tumor necrosis factor is a terminal mediator in galactosamine/endotoxin-induced hepatitis in mice.
Topics: Allopurinol; Animals; Chemical and Drug Induced Liver Injury; Eicosanoic Acids; Endotoxins; Epoprostenol; Galactosamine; Iloprost; Imidazoles; Male; Mice; Mice, Inbred Strains; Nifedipine; Superoxide Dismutase; Tumor Necrosis Factor-alpha; Verapamil; Xanthine Oxidase | 1989 |